Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Craig Wong-Pan
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters; questions recorded in 4).
- Questions
- 4on tracked calls
- Challenge rate
- 0%none of 4 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 4with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 4 of 4 questions from 1 company
RMDResMed4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
is that mainly through the price increases coming through? Or are there other factors
Show response
Aaron explained Q1 GM pressure (inflation outpacing productivity) reverses over Q2-Q4 via distribution-network optimization and modest price increases feathering in.
Calendar 2025 Q2
Just wanted to understand the Rest of World devices growth, kind of really good growth there
Show response
Mick confirmed 10% Rest of World device growth driven by multiple factors including Japan fleet purchases and tenders. Market growth remains mid-single digits. Brett noted strong results across numerous markets including improved growth in China.
Calendar 2024 Q4
SaaS revenue growth slowed a bit from the first quarter. Could you share what the growth rates were for the different businesses
Show response
Mick disclosed MEDIFOX growing above 8% group rate, Brightree in high-single-digits. Skilled nursing/senior living lagging post-COVID. Guided to high-single-digit top-line and double-digit NOP growth.
Calendar 2024 Q3
I just wanted to touch on the rest of world devices growth. 9% growth is good growth there
Show response
Mick confirmed growth is predominantly volume-driven rather than ASP from AirSense 10-to-11 mix shift, with strong competitive positioning across 140 countries.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| RMD ResMed | 4 | 0%none of 4 questions |
- RMDResMed · 4 questions0%none of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 1 | 0%none of 1 question | 1 |
| 2024 Q4 | 1 | 0%none of 1 question | 1 |
| 2025 Q1 | No questions recorded | — | — |
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | No questions recorded | — | — |
| 2025 Q4 | No questions recorded | — | — |
| 2026 Q1 | No questions recorded | — | — |
| 2026 Q2 | 1 | 0%none of 1 question | 1 |
- 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q1No questions recorded
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q3No questions recorded
- 2025 Q4No questions recorded
- 2026 Q1No questions recorded
- 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth3
- Geographic Expansion2
- Margin1
- Pricing1
- Cloud & AI1